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However, rather than suggesting that a
single case report “contradicts” the
anterior horn cell hypothesis, we sug-
gest that WNV-associated flaccid
paralysis be viewed as having a spec-
trum of causes, one of which certain-
ly is poliomyelitis like illness.  
The neuropathologic findings in
poliomyelitis (due to poliovirus,
WNV, or other viruses) are not
restricted focally to the anterior horn
cells (5). Demonstrating pathologic
changes as well as focal anterior horn
cell loss in the patient referenced by
Holman is in keeping with neu-
ropathologic findings in polio-
myelitis. Additionally, the presence of
a diffuse axonal polyneuropathy can-
not be concluded from Holman’s data.
Reduced compound motor axon
potentials and slowing of conduction
velocity could certainly be seen in
pathologic conditions affecting anteri-
or horn cells or spinal nerve roots. In
addition, reduced sensory nerve action
potentials in the median and ulnar
nerves alone, without documentation
of neuropathy in additional nerves,
cannot be used as evidence of a dif-
fuse axonal polyneuropathy, since
both of these nerves are commonly
prone to entrapment neuropathies.
Finally, the context in which the
preservation of this patient’s reflexes
is observed remains unclear.
Preserved “normal” deep-tendon
reflexes, in the setting of disease that
interrupts the reflex arc at any point,
are incongruous with established
physiologic and clinical concepts.
The seven patients observed by
our group clearly had a distinct clini-
cal syndrome with similar clinical
findings and electrodiagnostic
results. However, as demonstrated by
prior reports (3,5–7), multiple mecha-
nisms may lead to WNV-associated
flaccid paralysis. In fact, we
acknowledge a spectrum of cord,
root, and nerve involvement with
WVN flaccid paralysis.
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Typhus Group
Rickettsiae
Antibodies in Rural
Mexico 
To the Editor: In 2002, the risk of
transmission of epidemic typhus in the
state of Mexico was assessed by ana-
lyzing serum specimens from 393 res-
idents of previous typhogenic areas for
immunoglobulin (Ig) G antibodies
against Rickettsia prowazekii. Louse-
borne typhus has been a historic
scourge in Mexico. In 1576, in a pop-
ulation of 9 million, 2 million deaths
were attributed to epidemic typhus (1).
These illnesses primarily affected
indigenous peoples, who called the ill-
ness cocolixtle and matlazahuatl (2).
In 1951 a national campaign
against louseborne typhus was begun
by using newly developed technolog-
ic approaches, antibiotics, and insecti-
cides, resulting in decreases in the
incidence and case-fatality rate. In
1951 >1,000 cases and 737 deaths
caused by epidemic typhus were
reported in 18 states, and 6,781 local-
ities were identified as at risk (3). By
1965, only 36 cases and no deaths
were reported from 12 states with
4,841 localities at risk. Most cases
occurred during the cold months of
November–April. One third of cases
occurred in persons 19–29 years of
age with nearly 40% of the deaths in
patients aged 15–44 years. In 1979, 10
years had passed without any cases of
epidemic typhus reported in Mexico.
In the 1980s, three outbreaks of
typhus occurred in rural communities,
two in Chiapas and one in the state of
Mexico (4).
In the state of Mexico, during the
period 1893–1907, 7,353 epidemic
typhus deaths were reported (annual
mortality rate, 52.4/100,000 popula-
tion); from 1939 to 1943, 1,220 cases
were reported with 707 deaths (annu-
al mortality rate, 12.1/100,000 popu-
lation); and from 1959 to 1963, 64
cases were reported with 14 deaths
(annual mortality rate, 0.1/100,000
population) (3). In 1967, Atlaco-
mulco, a county in the state of Mexico
that had been free of typhus for 5
years, experienced an outbreak of
louseborne typhus associated with a
case of Brill-Zinsser disease in a 76-
year-old man who had a history of
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epidemic typhus. Forty cases were
diagnosed and one death occurred (3).
The last outbreak in the state of
Mexico occurred in 1983 in San Juan
Cote in San Felipe del Progreso
County, with 22 ill persons and one
death (4). Since then, a public health
program against Pediculus humanus
corporis has been conducted in five
counties with epidemiologic surveil-
lance for cases of reactivation of
latent infection. At the beginning of
the 1980s, the rate of infestation with
P. humanus corporis (mazahua) in the
indigenous population of the state of
Mexico was 100%; in 1988, 58%; and
in 1990, 15%. In 1999, indices of
infestation between 5% and 12% were
detected in this population (5).
In 2002, personnel from the office
of the Secretary of Health of the State
of Mexico evaluated the risk to the
population who lived in previously
typhogenic areas to measure the
impact of their programs (5). In a
cross-sectional study, 393 human
serum specimens were analyzed by
immunofluorescence assay (IFA) for
IgG antibodies against R. prowazekii,
and a titer of 64 or higher was consid-
ered positive (6). Antibodies against
R. prowazekii were detected in 74
serum samples (seropositivity, 18.8%;
26% for males and 18% for females).
The prevalence of antibodies to R.
prowazekii increased with age; 1–14
years of age (seropositivity 0%),
15–24 years (14%), 25–44 years
(17%), 45–64 years (24%), and >65
years (48%). Thirty-three (45%) of
the serum specimens had a titer of 64,
25 (34%) had a titer of 128, and 16
(22%) had a higher titer. All eight
serum specimens with a titer of >512
were from persons >45 years of age. 
The high seroprevalence suggests
that this population had extensive
exposure to the agent of typhus and its
louse vector in the past. The finding
of two subjects aged >65 years with a
titer of 1,024 and four subjects aged
>45 years with a titer of 512 suggests
reactivation of latent R. prowazekii
with a resulting boost in their anti-
body titers. These possible cases of
Brill-Zinsser disease were likely not
severely ill and recovered either with
antimicrobial treatment that was
effective against R. prowazekii or by
immune control of the infection with-
out a specific diagnosis. 
That IgG antibodies against R.
prowazekii are absent in young per-
sons suggests that this rickettsia has
not been circulating in this population
during recent years. The high sero-
prevalence suggests a human reser-
voir of latent R. prowazekii in this
population. The presence of human
body lice in this population indicates
that there is risk of spreading R.
prowazekii from an index patient with
Brill-Zinsser disease to persons in
contact with the patient.
Although the general lack of atten-
tion to R. prowazekii by scientists,
physicians, and public health agencies
would lead one to believe that typhus
has been eliminated as a public health
concern, the recent occurrence of a
large epidemic in Burundi (7), infect-
ed lice in Rwanda, an outbreak in
Russia, a documented case originating
in Algeria, and outbreaks every year
in Andean Peru (8) indicate that glob-
al attention should be directed to sur-
veillance, risk assessment, diagnostic
capability, and planning for rapid epi-
demic control to avoid establishing a
large reservoir of latent infection for
future epidemics originating from
recrudescent typhus in louse-infested
populations. Typhus likely poses a
similar threat in other parts of the
world including the Himalayas,
Andes, Afghanistan, and highlands of
Africa. Even in industrialized coun-
tries, the diagnosis of typhus is likely
to be delayed or missed. The potential
threat of bioterrorist-disseminated,
aerosol-transmitted typhus empha-
sizes that enhanced attention to and
knowledge of typhus are needed
throughout the world (9). The require-
ment concerns not only physician
awareness but also wide availability
and application of the most appropri-
ate diagnostic laboratory methods. 
Virginia E. Alcantara,* 
Esperanza G. Gallardo,† 
Chao Hong,* and David H. Walker* 
*WHO Collaborating Center for Tropical
Diseases, University of Texas Medical
Branch, Galveston Texas, USA; and
†Instituto de Salud del Estado de Mexico,
Toluca, Mexico
References
1. Fernández del Castillo F. El tifus en México
antes de Zinsser. In: Florescano E , Malvido
E, editors. Ensayos sobre la historia de las
epidemias en México. México City:
Instituto Mexicano del Seguro Social;
1982, vol. 1. p. 127–135.
2. Somolinos d’ Ardois G. La epidemia de
cocolixlte de 1545 señalada en un códice.
In: Florescano E, Malvido E, editors.
Ensayos sobre la historia de las epidemias
en México. México City: Instituto
Méxicano del Seguro Social; 1982, vol. 1.
p. 233.
3. Subsecretaria de Salubridad, Dirección
General de Epidemiología. Tifo transmitido
por piojos. México City: SSA; 1979. p.
19–74.
4. Dirección General de Epidemiología.
Boletín Epidemiologico EPI-1-85, p. 15. 
5. Gallardo EG, Díaz G, Hernández-Gómez
LA, Ortiz-Solalinde G, Ramírez-Hernández
JA, Medina I. La eliminacion del uso de
DDT en salud publica: su impacto en el
riesgo de transmision de tifo exantematico
en México. México City: Instituto de Salud
del Estado de México; 2000. p. 1–20. 
6. Philip RN, Casper EA, Ormsbee RA,
Peacock MG, Burgdorfer W.
Microimmuno-fluorescence test for the
serological study of Rocky Mountain spot-
ted fever and typhus. J Clin Microbiol
1976;3:51–61.
7. Raoult D, Ndihokubwayo JB, Tissot-
Dupont H, Faugere B, Abegbinni R, Birtles
RJ. Outbreak of epidemic typhus associated
with trench fever in Burundi. Lancet
1998;352:353–8.
8. Walker DH, Zavala-Velázquez JE, Ramírez
G, Olano JP. Emerging infectious diseases
in the Americas. In: Raoult D, Brouqui P,
editors. Rickettsiae and rickettsial diseases
at the turn of the third millenium. Paris:
Elsevier; 1999. p. 274–7.
9. Walker DH. Principles of the malicious use
of infectious agents to create terror.
Reasons for concern for organisms of the
genus  Rickettsia. Ann NY Acad Sci
2003;990:739–42.
550 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 10, No. 3, March 2004LETTERS
Address for correspondence:  David H. Walker,
Department of Pathology, University of Texas
Medical Branch, 301 University Blvd., Keiller
Bldg., Galveston, TX 77555-0609, USA; fax:
409-772-1850: email: dwalker@utmb.edu
Schistosoma
haematobium
Infection and 
Buruli Ulcer 
To the Editor: Buruli ulcer caused
by Mycobacterium ulcerans was rec-
ognized in 1997 as an emerging public
health problem by the World Health
Organization (WHO) (1). The disease
is found in tropical Africa, the
Americas, Australia, and Asia (2). In
Benin, severe disease with serious
complications is reported with increas-
ing frequency. Buruli ulcer causes
serious deformities and disability, par-
ticularly since amputating limbs is
sometimes required in cases of severe
disease such as osteomyelitis (3).
Given the effect on the quality of life
of those afflicted and the lack of ade-
quate treatment, identifying host risk
factors for Buruli ulcer is an important
research imperative (2). We investigat-
ed one potential risk factor, concurrent
infection with Schistosoma haemato-
bium.  Preliminary data indicate that
although S. haematobium is not a risk
factor for Buruli ulcer, it may be asso-
ciated with osteomyelitis.
Although Buruli ulcer and schisto-
somiasis each exist in the absence of
the other, close parallels exist between
their epidemiology, suggesting that
schistosomiasis could be one possible
risk factor for Buruli ulcer. Both dis-
eases are associated with the tropical
wetlands of west and central Africa.
Cases of both schistosomiasis and
Buruli ulcer have increased rapidly in
these areas since the 1980s, particu-
larly after irrigation and dam con-
struction. Buruli ulcer is most fre-
quent in children <15 years of age;
this group typically also has the high-
est prevalence and intensity of schis-
tosome infections. Schistosomiasis is
transmitted through contact with
infected water when the cercarial lar-
vae penetrate skin, and increasing evi-
dence exists that M. ulcerans prolifer-
ates in the bottom mud of stagnant
waters and may be harbored by aquat-
ic insects (4). 
An immunologic rationale for
linking the two diseases has been pro-
posed (5). Briefly, protective immune
responses to other mycobacterial dis-
eases are known to depend on a type 1
cellular response, typified by interfer-
on-gamma (IFN-γ). Helminth infec-
tions, on the other hand, are classical-
ly associated with type 2 responses,
typified by interleukin (IL)-4 and IL-
5 production. Therefore, a concurrent
infection with a bloodborne helminth
such as S. haematobium may skew the
immune response away from a poten-
tially protective type 1 response (5). 
A total of 113 patients were
recruited from Buruli ulcer treatment
centers in Lalo (Couffo Department)
and Zagnanado (Zou Department) in
Benin. A team of experienced sur-
geons clinically confirmed all cases of
Buruli ulcer. Controls (n = 429) were
recruited at random from residents of
eight current Buruli ulcer foci in the
Couffo Department. Past or current
Buruli ulcer patients were excluded
from the lottery for controls.
Clinical records reported no case
of intestinal schistosomiasis in this
area. This finding was confirmed by a
preliminary survey of 60 Buruli ulcer
patients, which detected no concur-
rent  S. mansoni by using the Kato
Katz method (6). Diagnosis of S.
haematobium (urinary schistosomia-
sis) was performed by filtering three
urine samples given on different days.
Neither cases nor controls were asked
to exercise (as is usual) before giving
urine samples because many Buruli
ulcer cases were immobile. All
patients positive for S. haematobium
were offered praziquantel treatment. 
In the entire participating popula-
tion, 11.5% (95% confidence interval
[CI] 6% to 19%) of Buruli ulcer cases
were positive for S. haematobium;
11.1% (95% CI 5% to 20%) of cases
from Lalo and 12.2% (95% CI 4% to
26%) from Zagnanado were positive.
The difference between the two cen-
ters was not statistically significant. Of
the 429 non-Buruli ulcer controls,
9.5% (95% CI 7% to 13%) were posi-
tive for S. haematobium. No statistical-
ly significant difference between cases
and controls was detected. The odds
ratio for S. haematobium infection in a
logistic regression model (which also
included age and sex) was 1.3 (95% CI
0.63 to 2.4). Prevalence of S. haemato-
bium infection did not significantly
differ between controls’ residence
(data not shown). Power analysis indi-
cates that about 4,000 cases and con-
trols would be required to find a statis-
tically significant difference at this
prevalence of schistosomiasis.
Both schistosomiasis and Buruli
ulcer are very local in nature; one vil-
lage can have substantial numbers of
cases whereas the next village could
have none. S. haematobium foci with
infection prevalence >50% do exist in
Benin but in different settlements
from the Buruli ulcer foci. Should a
Buruli ulcer focus coincide with a
schistosomiasis focus with a higher
prevalence of infection, some associa-
tion between the two diseases could
appear.
Detailed clinical information was
available for 36 patients tested for S.
haematobium. In all cases, at least two
of four laboratory tests were positive
for M. ulcerans. These tests were: 1)
acid-fast bacilli in a smear stained by
the Ziehl-Neelsen technique, 2) posi-
tive culture of M. ulcerans, 3)
histopathologic examination of a tis-
sue specimen, and 4) positive poly-
merase chain reaction (PCR) for M.
ulcerans DNA. Five patients had con-
firmed infection in bone samples, so
they were classified as osteomyelitis
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